These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25944686)

  • 1. Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia.
    Albano F; Zagaria A; Anelli L; Coccaro N; Tota G; Brunetti C; Minervini CF; Impera L; Minervini A; Cellamare A; Orsini P; Cumbo C; Casieri P; Specchia G
    Oncotarget; 2015 May; 6(15):13269-77. PubMed ID: 25944686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
    Lang L; Li HM; Liu H; Wang YM; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia.
    Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z
    PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: possibility for molecular diagnosis without lagging behind the morphological analyses.
    Sueki A; Matsuda K; Taira C; Yamaguchi A; Koeda H; Takagi F; Kobayashi Y; Sugano M; Honda T
    Clin Chim Acta; 2013 Jan; 415():276-8. PubMed ID: 23159843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia.
    Zhu HH; Qin YZ; Lai YY; Shi HX; Liu YR; Jiang B; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):872-8. PubMed ID: 23998577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No prognostic significance of normalized copy number of PML-RARA transcript at diagnosis in patients with acute promyelocytic leukemia.
    Rasekh EO; Elsayed GM; Fathy S
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):119-125. PubMed ID: 32735792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT.
    Nasilowska-Adamska B; Majewski M; Seferynska I; Szczepinski A; Tomaszewska A; Prochorec-Sobieszek M; Guz K; Torbicki A; Warzocha K; Marianska B
    Ann Transplant; 2007; 12(3):33-8. PubMed ID: 18290568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
    Shigeto S; Matsuda K; Yamaguchi A; Sueki A; Uehara M; Sugano M; Uehara T; Honda T
    Clin Chim Acta; 2016 Jan; 453():38-41. PubMed ID: 26656442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis.
    Fan H; Ortega V; Fanasch HM; Wang Y; Holder KN; Higgins RA; Mendiola C; Mohamed G; Vadlamudi K; Velagaleti G
    Eur J Haematol; 2014 Oct; 93(4):354-8. PubMed ID: 24673420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial.
    Diverio D; Rossi V; Avvisati G; De Santis S; Pistilli A; Pane F; Saglio G; Martinelli G; Petti MC; Santoro A; Pelicci PG; Mandelli F; Biondi A; Lo Coco F
    Blood; 1998 Aug; 92(3):784-9. PubMed ID: 9680345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
    Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
    Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.
    Walz C; Grimwade D; Saussele S; Lengfelder E; Haferlach C; Schnittger S; Lafage-Pochitaloff M; Hochhaus A; Cross NC; Reiter A
    Genes Chromosomes Cancer; 2010 May; 49(5):471-9. PubMed ID: 20155840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
    Yoon JH; Kim HJ; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    J Hematol Oncol; 2017 Jan; 10(1):30. PubMed ID: 28114959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH.
    Han JY; Kim KE; Kim KH; Park JI; Kim JS
    Leuk Res; 2007 Feb; 31(2):239-43. PubMed ID: 16797070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3.
    Cao Y; Yao L; Liu Y; Gu Q; Dong W; Wang Z; Wang F; Lin R; Xie X; Cen J; Chen S; Gu W
    Acta Haematol; 2019; 142(2):98-104. PubMed ID: 31085908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
    Gao N; Wang XX; Sun JR; Yu WZ; Li XZ
    Ann Hematol; 2017 May; 96(5):711-718. PubMed ID: 28238096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.